A response to the commentary “Indolamine 2,3-dioxygenase regulation and neuropsychiatric symptoms” by Loftis, J.M. on “Serotonin and interleukin-6: The role of genetic polymorphisms in IFN-induced neuropsychiatric symptoms” by Udina, M., Moreno-España, J., Navinés, R., Gimenez, D., Langohr, K., Gratacòs, M., Capuron, L., de la Torre, R., Solà, R., Martin-Santos, R. http:\\dx.doi.org/10.1016/j.psyneuen.2013.03.007
2013 ◽
Vol 38
(9)
◽
pp. 1830-1831
◽
2013 ◽
Vol 38
(9)
◽
pp. 1803-1813
◽
2019 ◽
Vol 19
(5)
◽
pp. 428-437
◽
Keyword(s):
Keyword(s):
2021 ◽